A 65-year-old with stable ischemic heart disease receives a contemporary drug-eluting stent (DES). He is tolerating aspirin and clopidogrel without bl...

Question

A 65-year-old with stable ischemic heart disease receives a contemporary drug-eluting stent (DES). He is tolerating aspirin and clopidogrel without bleeding. What is the minimum recommended duration of dual antiplatelet therapy (DAPT) after elective PCI for stable disease?

Accepted Answer

6 months

Answer

1 month

Answer

3 months

Answer

4 months

Answer

12 months

us-abim MCQ (SBA): Post‑PCI Antiplatelet Therapy

A 65-year-old with stable ischemic heart disease receives a contemporary drug-eluting stent (DES). He is tolerating aspirin and clopidogrel without bleeding. What is the minimum recommended duration of dual antiplatelet therapy (DAPT) after elective PCI for stable disease?